179 related articles for article (PubMed ID: 22736254)
1. T cells from indolent CLL patients prevent apoptosis of leukemic B cells in vitro and have altered gene expression profile.
Kiaii S; Kokhaei P; Mozaffari F; Rossmann E; Pak F; Moshfegh A; Palma M; Hansson L; Mashayekhi K; Hojjat-Farsangi M; Österborg A; Choudhury A; Mellstedt H
Cancer Immunol Immunother; 2013 Jan; 62(1):51-63. PubMed ID: 22736254
[TBL] [Abstract][Full Text] [Related]
2. Autologous T lymphocytes may specifically recognize leukaemic B cells in patients with chronic lymphocytic leukaemia.
Rezvany MR; Jeddi-Tehrani M; Rabbani H; Lewin N; Avila-Cariño J; Osterborg A; Wigzell H; Mellstedt H
Br J Haematol; 2000 Nov; 111(2):608-17. PubMed ID: 11122109
[TBL] [Abstract][Full Text] [Related]
3. Guilty bystanders: nurse-like cells as a model of microenvironmental support for leukemic lymphocytes.
Filip AA; Ciseł B; Wąsik-Szczepanek E
Clin Exp Med; 2015 Feb; 15(1):73-83. PubMed ID: 24337970
[TBL] [Abstract][Full Text] [Related]
4. Autologous T cells expressing the oncogenic transcription factor KLF6-SV1 prevent apoptosis of chronic lymphocytic leukemia cells.
Kokhaei P; Hojjat-Farsangi M; Mozaffari F; Moshfegh A; Pak F; Rashidy-Pour A; Palma M; Hansson L; Österborg A; Mellstedt H
PLoS One; 2018; 13(2):e0192839. PubMed ID: 29432497
[TBL] [Abstract][Full Text] [Related]
5. Differential induction of apoptosis by fludarabine monophosphate in leukemic B and normal T cells in chronic lymphocytic leukemia.
Consoli U; El-Tounsi I; Sandoval A; Snell V; Kleine HD; Brown W; Robinson JR; DiRaimondo F; Plunkett W; Andreeff M
Blood; 1998 Mar; 91(5):1742-8. PubMed ID: 9473241
[TBL] [Abstract][Full Text] [Related]
6. Study of the quantitative, functional, cytogenetic, and immunoregulatory properties of bone marrow mesenchymal stem cells in patients with B-cell chronic lymphocytic leukemia.
Pontikoglou C; Kastrinaki MC; Klaus M; Kalpadakis C; Katonis P; Alpantaki K; Pangalis GA; Papadaki HA
Stem Cells Dev; 2013 May; 22(9):1329-41. PubMed ID: 23249221
[TBL] [Abstract][Full Text] [Related]
7. Vdelta1 T lymphocytes from B-CLL patients recognize ULBP3 expressed on leukemic B cells and up-regulated by trans-retinoic acid.
Poggi A; Venturino C; Catellani S; Clavio M; Miglino M; Gobbi M; Steinle A; Ghia P; Stella S; Caligaris-Cappio F; Zocchi MR
Cancer Res; 2004 Dec; 64(24):9172-9. PubMed ID: 15604289
[TBL] [Abstract][Full Text] [Related]
8. Leukemia-associated monoclonal and oligoclonal TCR-BV use in patients with B-cell chronic lymphocytic leukemia.
Rezvany MR; Jeddi-Tehrani M; Wigzell H; Osterborg A; Mellstedt H
Blood; 2003 Feb; 101(3):1063-70. PubMed ID: 12393705
[TBL] [Abstract][Full Text] [Related]
9. Chronic lymphocytic leukemia B cells inhibit spontaneous Ig production by autologous bone marrow cells: role of CD95-CD95L interaction.
Sampalo A; Navas G; Medina F; Segundo C; Cámara C; Brieva JA
Blood; 2000 Nov; 96(9):3168-74. PubMed ID: 11049999
[TBL] [Abstract][Full Text] [Related]
10. Identification and characterization of distinct IL-17F expression patterns and signaling pathways in chronic lymphocytic leukemia and normal B lymphocytes.
Sherry B; Jain P; Chiu PY; Leung L; Allen SL; Kolitz JE; Rai KR; Barrientos J; Liang S; Hawtin R; Chiorazzi N
Immunol Res; 2015 Dec; 63(1-3):216-27. PubMed ID: 26478573
[TBL] [Abstract][Full Text] [Related]
11. Activated autologous T cells exert an anti-B-cell chronic lymphatic leukemia effect in vitro and in vivo.
Di Ianni M; Moretti L; Terenzi A; Bazzucchi F; Del Papa B; Bazzucchi M; Ciurnelli R; Lucchesi A; Sportoletti P; Rosati E; Marconi PF; Falzetti F; Tabilio A
Cytotherapy; 2009; 11(1):86-96. PubMed ID: 19153855
[TBL] [Abstract][Full Text] [Related]
12. Signaling molecules and cytokine production in T cells of patients with B-cell chronic lymphocytic leukemia (B-CLL): comparison of indolent and progressive disease.
Kiaii S; Choudhury A; Mozaffari F; Kimby E; Osterborg A; Mellstedt H
Med Oncol; 2005; 22(3):291-302. PubMed ID: 16110140
[TBL] [Abstract][Full Text] [Related]
13. Morphological variants of leukemic cells in B chronic lymphocytic leukemia are associated with different T cell and NK cell abnormalities.
Reyes E; Prieto A; Carrion F; Garcia-Suarez J; Esquivel F; Alvarez-Mon M
Am J Hematol; 1997 Aug; 55(4):175-82. PubMed ID: 9257876
[TBL] [Abstract][Full Text] [Related]
14. Expression feature of CD3, FcεRIγ, and Zap-70 in patients with chronic lymphocytic leukemia.
Huang L; Chen S; Zha X; Yang L; Li B; Yu Z; Wang L; Li Y
Hematology; 2012 Mar; 17(2):71-5. PubMed ID: 22664044
[TBL] [Abstract][Full Text] [Related]
15. Expression and function of the FAS antigen in B chronic lymphocytic leukemia and hairy cell leukemia.
Panayiotidis P; Ganeshaguru K; Foroni L; Hoffbrand AV
Leukemia; 1995 Jul; 9(7):1227-32. PubMed ID: 7543175
[TBL] [Abstract][Full Text] [Related]
16. Effects of preactivated autologous T lymphocytes on CD80, CD86 and CD95 expression by chronic lymphocytic leukemia B cells.
Romano C; De Fanis U; Sellitto A; Dalla Mora L; Chiurazzi F; Giunta R; Rotoli B; Lucivero G
Leuk Lymphoma; 2003 Nov; 44(11):1963-71. PubMed ID: 14738151
[TBL] [Abstract][Full Text] [Related]
17. B-cell chronic lymphocytic leukemia-derived dendritic cells stimulate allogeneic T-cell response and express chemokines involved in T-cell migration.
Łuczyński W; Stasiak-Barmuta A; Piszcz J; Iłendo E; Kowalczuk O; Krawczuk-Rybak M
Neoplasma; 2007; 54(6):527-35. PubMed ID: 17949237
[TBL] [Abstract][Full Text] [Related]
18. Chronic lymphocytic leukemia-like monoclonal B-cell lymphocytosis exhibits an increased inflammatory signature that is reduced in early-stage chronic lymphocytic leukemia.
Blanco G; Puiggros A; Sherry B; Nonell L; Calvo X; Puigdecanet E; Chiu PY; Kieso Y; Ferrer G; Palacios F; Arnal M; Rodríguez-Rivera M; Gimeno E; Abella E; Rai KR; Abrisqueta P; Bosch F; Calon A; Ferrer A; Chiorazzi N; Espinet B
Exp Hematol; 2021 Mar; 95():68-80. PubMed ID: 33421548
[TBL] [Abstract][Full Text] [Related]
19. Expansion of effector T cells associated with decreased PD-1 expression in patients with indolent B cell lymphomas and chronic lymphocytic leukemia.
Tonino SH; van de Berg PJ; Yong SL; ten Berge IJ; Kersten MJ; van Lier RA; van Oers MH; Kater AP
Leuk Lymphoma; 2012 Sep; 53(9):1785-94. PubMed ID: 22397719
[TBL] [Abstract][Full Text] [Related]
20. Expression levels of CD38 on leukemic B cells but not on non-leukemic T cells are comparably stable over time and predict the course of disease in patients with chronic lymphocytic leukemia.
Eisele L; Haddad T; Sellmann L; Dührsen U; Dürig J
Leuk Res; 2009 Jun; 33(6):775-8. PubMed ID: 18922578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
